Evidence map›Paper›PMID 30045833›Full record

ArticleJMIR research protocols2018

Patient Preferences and Willingness to Pay for Cervical Cancer Prevention in Zambia: Protocol for a Multi-Cohort Discrete Choice Experiment.

Sujha Subramanian, Yevgeniya Kaganova, Yuying Zhang, Sonja Hoover, Namakau Nyambe, Leeya Pinder, Carla Chibwesha, Sharon Kapambwe, Groesbeck Parham

Open access · goldAbstract read
In one paragraph

Article in JMIR research protocols, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Sujha SubramanianRTI International, Waltham, MA, United States.ORCID http://orcid.org/0000-0003-2415-9721
Yevgeniya KaganovaRTI International, Waltham, MA, United States.ORCID http://orcid.org/0000-0002-3879-5561
Yuying ZhangRTI International, Waltham, MA, United States.ORCID http://orcid.org/0000-0003-2280-2509
Sonja HooverRTI International, Waltham, MA, United States.ORCID http://orcid.org/0000-0002-6205-1212
Namakau NyambeUniversity of North Carolina, Lusaka, Zambia.ORCID http://orcid.org/0000-0002-0996-5744
Leeya PinderUniversity Teaching Hospital, Lusaka, Zambia.ORCID http://orcid.org/0000-0002-8929-7810
Carla ChibweshaUniversity of North Carolina, Chapel Hill, NC, United States.ORCID http://orcid.org/0000-0002-0397-2994
Sharon KapambweMinistry of Health, Zambia, Zambia.ORCID http://orcid.org/0000-0001-9800-9385
Groesbeck ParhamUniversity of Zambia, Lusaka, Zambia.ORCID http://orcid.org/0000-0001-5922-5990
RTI International · USMinistry of Health · ZMUniversity of North Carolina at Chapel Hill · USUniversity of Zambia · ZMUniversity Teaching Hospital · ZM

Funding

Evidence-based Approaches, Financing and Tools for Cost-Effective Scale-up Cervical Cancer Prevention in Sub-Saharan AfricaR01CA200845 · NCI · RESEARCH TRIANGLE INSTITUTE · PI SUBRAMANIAN, SUJHA · 2016 to 2018
$1.4M
NCI NIH HHS R01 CA200845
6 · The paper itself

Abstract

backgroundAlthough most countries in southern Africa have cervical cancer screening programs, these programs generally fail to reach a significant majority of women because they are often implemented as pilot or research projects, and this limits their scope and ability to scale up screening. Some countries have planned larger-scale programs, but these have either never been implemented or have not been successfully scaled up. Most of the global burden of cervical cancer is experienced in countries with limited resources, and mortality from cervical cancer is the most common cause of cancer-related deaths among women in Sub-Saharan Africa.

objectiveThe purpose of this study is to learn about preferences for cervical cancer screening in Zambia, to identify barriers and facilitators for screening uptake, and to evaluate willingness to pay for screening services to support the scaling up of cervical cancer screening programs.

methodsWe will conduct a discrete choice experiment by interviewing women and men and asking them to choose among constructed scenarios with varying combinations of attributes relevant to cervical cancer screening. To inform the discrete choice experiment, we will conduct focus groups and interviews about general knowledge and attitudes about cervical screening, perception about the availability of screening, stigma associated with cancer and HIV, and payment for health care services. For the discrete choice experiment, we will have a maximum design of 120 choice sets divided into 15 sets of 8 tasks each with a sample size of 320-400 respondents. We will use a hierarchical Bayesian estimation procedure to assess attributes at the following two levels: group and individual levels.

resultsThe model will generate preferences for attributes to assess the most important features and allow for the assessment of differences among cohorts. We will conduct policy simulations reflecting potential changes in the attributes of the screening facilities and calculate the projected changes in preference for choosing to undergo cervical cancer screening. The findings from the discrete choice experiment will be supplemented with interviews, focus groups, and patient surveys to ensure a comprehensive and context-based interpretation of the results.

conclusionsBecause willingness to pay for cervical cancer screening has not been previously assessed, this will be a unique and important contribution to the literature. This study will take into account the high HIV prevalence in Sub-Saharan Africa and prevailing gender attitudes to identify an optimal package of interventions to reduce cervical cancer incidence. This simulation of women's decisions (and men's support) to undergo screening will lay the foundation for understanding the stated preferences and willingness to pay to help design future screening programs. REGISTERED REPORT IDENTIFIER: RR1-10.2196/10429.

Indexed as

cervical cancer preventiondiscrete choice experimenteconomic evaluation

Identifiers

PMID30045833
PMCPMC6083044
OpenAlexW2804839754

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.